Cross-talk among bone cells

Current Opinion in Nephrology and Hypertension

Volumn 18, Issue 4, 2009, Pages 292-297

  Matsuo, Koichi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MATRIX; BONE REMODELING; CELL ACTIVATION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL SURVIVAL; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; PH; PRIORITY JOURNAL; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; BONE REMODELING; CALCIUM; CELL COMMUNICATION; CELL DIFFERENTIATION; HUMANS; HYDROGEN-ION CONCENTRATION; NFATC TRANSCRIPTION FACTORS; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES;

EID: 67849084531     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32832b75f1     Document Type: Review

References (68)

1. Del Fattore A, Teti A, Rucci N. Osteoclast receptors and signaling. Arch Biochem Biophys 2008; 473:147-160.
2. Nishimura R, Hata K, Ikeda F, et al. Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J Bone Miner Metab 2008; 26:203-212.
3. Sims NA, Gooi JH. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 2008; 19:444-451.
4. Martin TJ, Seeman E. Bone remodelling: its local regulation and the emergence of bone fragility. Best Pract Res Clin Endocrinol Metab 2008; 22:701-722.
5. Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys 2008; 473:201-209.
6. Khosla S, Westendorf JJ, Oursler MJ. Building bone to reverse osteoporosis and repair fractures. J Clin Invest 2008; 118:421-428.
7. Masuyama R, Vriens J, Voets T, et al. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. Cell Metab 2008; 8:257-265.
8. 2+ oscillation-independent NFATc1 activation during osteoclastogenesis. Proc Natl Acad Sci U S A 2008; 105:8643-8648.
9. 3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice. Mol Endocrinol 2008; 22:1370-1381.
10. Takagi K, Kudo A. Bone marrow stromal cell lines having high potential for osteoclast-supporting activity express PPARγ1 and show high potential for differentiation into adipocytes. J Bone Miner Metab 2008; 26:13-23.
11. Zheng F, Liang H, Liu R, et al. Parathyroid hormone-related protein regulates osteoclast inhibitory lectin expression via multiple signaling pathways in osteoblast-like cells. Endocrine 2009; 35:47-56.
12. Kartsogiannis V, Sims NA, Quinn JM, et al. Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivo. J Biol Chem 2008; 283:30850-30860.
13. Glass DA 2nd, Bialek P, Ahn JD, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005; 8:751-764.
14. Krum SA, Miranda-Carboni GA, Hauschka PV, et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J 2008; 27:535-545.
15. Sanchez-Fernandez MA, Gallois A, Riedl T, et al. Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor b signaling. PLoS ONE 2008; 3:e3537.
16. Zhao C, Irie N, Takada Y, et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 2006; 4:111-121.
17. Allan EH, Hausler KD, Wei T, et al. EphrinB2 regulation by parathyroid hormone (PTH) and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res 2008; 23:1170-1181.
18. Berry JE, Pettway GJ, Cordell KG, et al. JunB as a potential mediator of PTHrP actions: new gene targets Ephrin B1 and VCAM-1. Oral Dis 2008; 14:713-726.
19. Kwan Tat S, Pelletier JP, Amiable N, et al. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Arthritis Rheum 2008; 58:3820-3830.
20. Irie N, Takada Y, Watanabe Y, et al. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem (March 19, 2009) 10.1074/jbc.M807598200
21. Karsdal MA, Neutzsky-Wulff AV, Dziegiel MH, et al. Osteoclasts secrete nonbone derived signals that induce bone formation. Biochem Biophys Res Commun 2008; 366:483-488.
22. Pederson L, Ruan M, Westendorf JJ, et al. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 2008; 105:20764-20769.
23. Garimella R, Tague SE, Zhang J, et al. Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling. J Histochem Cytochem 2008; 56:569-577.
24. Kimura H, Kwan KM, Zhang Z, et al. Cthrc1 is a positive regulator of osteoblastic bone formation. PLoS ONE 2008; 3:e3174.
25. Engin F, Yao Z, Yang T, et al. Dimorphic effects of notch signaling in bone homeostasis. Nat Med 2008; 14:299-305.
26. Hilton MJ, Tu X, Wu X, et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 2008; 14:306-314.
27. Zanotti S, Smerdel-Ramoya A, Stadmeyer L, et al. Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology 2008; 149:3890-3899.
28. Bai S, Kopan R, Zou W, et al. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J Biol Chem 2008; 283:6509-6518.
29. Fukushima H, Nakao A, Okamoto F, et al. The association of Notch2 and NF-κB accelerates RANKL-induced osteoclastogenesis. Mol Cell Biol 2008; 28:6402-6412.
30. Choudhary S, Halbout P, Alander C, et al. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins. J Bone Miner Res 2007; 22:1002-1010.
31. Bonnelye E, Chabadel A, Saltel F, et al. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008; 42:129-138.
32. Chang MK, Raggatt LJ, Alexander KA, et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 2008; 181:1232-1244.
33. Pettit AR, Chang MK, Hume DA, et al. Osteal macrophages: a new twist on coupling during bone dynamics. Bone 2008; 43:976-982.
34. Hauge EM, Qvesel D, Eriksen EF, et al. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001; 16:1575-1582.
35. Andersen TL, Sondergaard TE, Skorzynska KE, et al. A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol 2009; 174:239-247.
36. Iwasaki R, Ninomiya K, Miyamoto K, et al. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity. Biochem Biophys Res Commun 2008; 377:899-904.
37. + antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 2008; 453:788-792.
38. Villa A, Guerrini MM, Cassani B, et al. Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int 2009; 84:1-12.
39. Kaunitz JD, Yamaguchi DT. TrAP TNAP. Ecto-purinergic signaling, and bone remodeling. J Cell Biochem 2008; 105:655-662.
40. Akiba Y, Mizumori M, Guth PH, et al. Duodenal brush border intestinal alkaline phosphatase activity affects bicarbonate secretion in rats. Am J Physiol Gastrointest Liver Physiol 2007; 293:G1223-1233.
41. - anion exchanger SLC4A2 is required for proper osteoclast differentiation and function. Proc Natl Acad Sci U S A 2008; 105:16934-16939.
42. - exchanger Ae2 results in osteopetrosis in mice. Proc Natl Acad Sci U S A 2009; 106:1638-1641.
43. Orriss IR, Key ML, Colston KW, et al. Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 2009; 106:109-118.
44. Arnett TR. Extracellular pH regulates bone cell function. J Nutr 2008; 138:415S-418S.
45. Hessle L, Johnson KA, Anderson HC, et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A 2002; 99:9445-9449.
46. Karsdal MA, Martin TJ, Bollerslev J, et al. Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 2007; 22:487-494.
47. Neutzsky-Wulff AV, Karsdal MA, Henriksen K. Characterization of the bone phenotype in ClC-7-deficient mice. Calcif Tissue Int 2008; 83:425-437.
48. Henriksen K, Sorensen MG, Jensen VK, et al. Ion transporters involved in acidification of the resorption lacuna in osteoclasts. Calcif Tissue Int 2008; 83:230-242.
49. Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. Bone 2008; 42:606-615.
50. Lanyon LE. Osteocytes, strain detection, bone modeling and remodeling. Calcif Tissue Int 1993; 53 (Suppl 1):S102-106; discussion S106-S107.
51. Kogianni G, Mann V, Noble BS. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res 2008; 23:915-927.
52. Heino TJ, Hentunen TA, Vaananen HK. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem 2002; 85:185-197.
53. Tan SD, de Vries TJ, Kuijpers-Jagtman AM, et al. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption. Bone 2007; 41:745-751.
54. Civitelli R. Cell-cell communication in the osteoblast/osteocyte lineage. Arch Biochem Biophys 2008; 473:188-192.
55. Laird DW. Closing the gap on autosomal dominant connexin-26 and connexin-43 mutants linked to human disease. J Biol Chem 2008; 283:2997-3001.
56. McLachlan E, Plante I, Shao Q, et al. ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation. J Bone Miner Res 2008; 23:928-938.
57. Huiskes R, Ruimerman R, van Lenthe GH, et al. Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 2000; 405:704-706.
58. Tanck E, Hannink G, Ruimerman R, et al. Cortical bone development under the growth plate is regulated by mechanical load transfer. J Anat 2006; 208:73-79.
59. van Oers RF, Ruimerman R, Tanck E, et al. A unified theory for osteonal and hemi-osteonal remodeling. Bone 2008; 42:250-259.
60. van Oers RF, Ruimerman R, van Rietbergen B, et al. Relating osteon diameter to strain. Bone 2008; 43:476-482.
61. Mulvihill BM, McNamara LM, Prendergast PJ. Loss of trabeculae by mechanobiological means may explain rapid bone loss in osteoporosis. J R Soc Interface 2008; 5:1243-1253.
62. Pivonka P, Zimak J, Smith DW, et al. Model structure and control of bone remodeling: a theoretical study. Bone 2008; 43:249-263.
63. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 2008; 473:231-236.
64. Takeda S. Central control of bone remodelling. J Neuroendocrinol 2008; 20:802-807.
65. Wong IP, Zengin A, Herzog H, et al. Central regulation of bone mass. Semin Cell Dev Biol 2008; 19:452-458.
66. Yadav VK, Ryu JH, Suda N, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008; 135:825-837.
67. Long F. When the gut talks to bone. Cell 2008; 135:795-796.
68. Williams BO, Insogna KL. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res 2009; 24:171-178.